Tuberculosis Costs in Spain and Related Factors
| Autor: | Manuel Ángel Villanueva, Martí Casals, Ana Bustamante, Fernando Álvarez-Navascués, Marta García-Clemente, Antón Penas, José Antonio Gullón, Joan A. Caylà, Luis Anibarro, María Ángeles Jiménez, José-María García-García, Jose A. Caminero, Teresa Rodrigo |
|---|---|
| Rok vydání: | 2016 |
| Předmět: |
Adult
Male Pediatrics medicine.medical_specialty Multivariate analysis Tuberculosis Adolescent Antitubercular Agents Emigrants and Immigrants Logistic regression 03 medical and health sciences Indirect costs Young Adult 0302 clinical medicine Sex Factors Cost of Illness Confidence Intervals Odds Ratio Medicine Humans 030212 general & internal medicine Prospective Studies Aged Aged 80 and over business.industry Diagnostic Tests Routine Age Factors General Medicine Odds ratio Health Care Costs Length of Stay Middle Aged medicine.disease Confidence interval Hospitalization 030228 respiratory system Spain Sick leave Female Health Expenditures Sick Leave business Contact tracing |
| Zdroj: | Archivos de bronconeumologia. 52(12) |
| ISSN: | 1579-2129 |
| Popis: | Objective To analyze the direct and indirect costs of diagnosis and management of tuberculosis (TB) and associated factors. Patients and methods Prospective study of patients diagnosed with TB between September 2014 and September 2015. We calculated direct (hospital stays, visits, diagnostic tests, and treatment) and indirect (sick leave and loss of productivity, contact tracing, and rehabilitation) costs. The following cost-related variables were compared: age, gender, country of origin, hospital stays, diagnostic testing, sensitivity testing, treatment, resistance, directed observed therapy (DOT), and days of sick leave. Proportions were compared using the chi-squared test and significant variables were included in a logistic regression analysis to calculate odds ratio (OR) and corresponding 95% confidence intervals. Results 319 patients were included with a mean age of 56.72±20.79 years. The average cost was €10,262.62±14,961.66, which increased significantly when associated with hospital admission, polymerase chain reaction, sputum smears and cultures, sensitivity testing, chest computed tomography, pleural biopsy, drug treatment longer than nine months, DOT and sick leave. In the multivariate analysis, hospitalization (OR=96.8; CI 29–472), sensitivity testing (OR=4.34; CI 1.71–12.1), chest CT (OR=2.25; CI 1.08–4.77), DOT (OR=20.76; CI 4.11–148) and sick leave (OR=26.9; CI 8.51–122) showed an independent association with cost. Conclusion Tuberculosis gives rise to significant health spending. In order to reduce these costs, more control of transmission, and fewer hospital admissions would be required. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect